SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000947871-22-000940
Filing Date
2022-08-30
Accepted
2022-08-30 16:37:12
Documents
2
Group Members
ORBIMED ROF II LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 9 ss1288981_sc13da.htm SC 13D/A 96494
2 JOINT FILING AGREEMENT ss1288981_ex9901.htm EX-99.1 5397
  Complete submission text file 0000947871-22-000940.txt   103595
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Subject) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86224 | Film No.: 221215026
SIC: 2836 Biological Products, (No Diagnostic Substances)